Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin in Diabetic Patients With COVID-19
NCT04371978Phase 3Terminated
- Sponsor
- Rabin Medical Center
- Start
- Oct 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linagliptin in coronavirus disease 2019 (COVID-19), sponsored by Rabin Medical Center. Started Oct 2020; status: terminated.
02
Drugs
linagliptin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04371978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04371978.